Dan Eik Høfsten
机构: Copenhagen Universiy Hospital, Rigshospitalet
每年引用次数
引用次数
引用: 6,003
H-指数: 33
I10-指数 : 59
出版物: 161
Age and effect of implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure
L. Videbaek , Jens J Thune , Hans Eiskjær , F.H Steffensen
European Journal of Heart Failure 19
1
2017
Results of voluntary cardiovascular examination of elite athletes in Denmark: Proposal for Nordic collaboration.
S. G. Tischer , N. Mattsson , M. Storgaard , D. E. Høfsten
Scandinavian Journal of Medicine & Science in Sports 26 ( 1) 64 -73
7
2016
Simple Risk Stratification at Admission to Identify Patients With Reduced Mortality From Primary Angioplasty
Jens Jakob Thune , Dan Eik Hoefsten , Matias Greve Lindholm , Leif Spange Mortensen
Circulation 112 ( 13) 2017 -2021
119
2005
Bleeding episodes in" complete, staged" versus" culprit only" revascularization in patients with multivessel disease and ST-segment elevation myocardial infarction-a DANAMI-3-Primulti substudy
G Sadjadieh , T Engstrøm , S Helqvist , DE Høfsten
European Heart Journal 36 681 -681
1
2015
Myocardial Damage After ST-Segment Elevation Myocardial Infarction According to the Use of Bivalirudin or Heparin. A Cardiac Magnetic Resonance Substudy of the DANAMI3 trial.
MM Schoos , L Nepper-Christensen , KA Ahtarovski , K Kyhl
EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
2019
P1635 Prognostic significance of transient myocardial ischaemia after primary angioplasty for ST-elevation myocardial infarction
D Høfsten , K Egstrup , H Mølgaard , DANAMI-2 Study Group
European Heart Journal 24 ( 5) 303
2003
P1633 Prevalence and prognostic value of arrhythmic propensity after primary angioplasty for ST-segment elevation myocardial infarction
D Høfsten , K Egstrup , H Mølgaard , DANAMI-2 study group
European Heart Journal 24 ( 5) 303
2003
2064 Prognostic value of heart rate variability after ST-segment elevation myocardial infarction treated with fibrinolysis versus primary angioplasty
H Mølgaard , B Lund , D Høfsten , K Egstrup
European Heart Journal 24 ( 5) 381
2003
Prevalence and prognostic significance of pathological glucose metabolism in acute myocardial infarction
Kenneth Egstrup , Dan Eik Høfsten , Jørgen Hangaard , Finn Lund Henriksen
Ugeskrift for Læger 170 ( 11) 940 -942
2008
Øget venstre ventrikelmasse hos non-hypertensive patienter indlagt med førstegangs myokardieinfarkt og dysglykæmi
Kenneth Egstrup , Brian Bridal Løgstrup , Thomas Brøcher Christophersen , Dan Eik Høfsten
Årsmøde Dansk Cardiologisk Selskab 2017
2017
Metformin in Patients with Chronic Heart Failure
Christian Hassager , Søren Mellemkjær , Helene Nørrelund , Hans Eiskjær
Diabetes 2 ( 3)
2020
MIDREGIONAL PROADRENOMEDULLIN: A PROGNOSTIC MARKER OF MORTALITY AND HEART FAILURE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Alexander Christian Falkentoft , Rasmus Rørth , Dan Eik Høfsten , Kasper Iversen
Journal of the American College of Cardiology 69 ( 11) 11
3
2017
Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial
E. Marc Jolicoeur , Nandini Dendukuri , Patrick Belisle , Grégoire Range
Canadian Journal of Cardiology 36 ( 11) 1805 -1814
5
2020
Clinical characteristics and lipid lowering treatment of patients initiated on proprotein convertase subtilisin-kexin type 9 inhibitors: a nationwide cohort study.
Jakob Solgaard Jensen , Peter Ejvin Weeke , Lia Evi Bang , Dan Eik Høfsten
BMJ Open 9 ( 4)
1
2019
Dysglycemia and increased left ventricle mass in normotensive patients admitted with a first myocardial infarction: prognostic implications of dysglycemia during 14 years of follow-up
Gokulan Pararajasingam , Brian Bridal Løgstrup , Dan Eik Høfsten , Thomas Brøcher Christophersen
BMC Cardiovascular Disorders 19 ( 1) 103
1
2019
The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT).
Henrik Wiggers , Lars Køber , Gunnar Gislason , Morten Schou
American Heart Journal 231 137 -146
19
2021
Prevalence and prognostic implications of ST-segment deviations from ambulatory holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a danish trial in acute myocardial infarction-2 substudy)
Lars Idorn , Dan Eik Høfsten , Kristian Wachtell , Henning Mølgaard
American Journal of Cardiology 100 ( 6) 937 -943
3
2007
Bleeding episodes in "complete, staged" versus "culprit only" revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy.
Golnaz Sadjadieh , Thomas Engstrøm , Steffen Helqvist , Dan Eik Høfsten
Eurointervention 12 ( 10) 1231 -1238
4
2016
To defer, or not to defer, that is the question.
Henning Kelbæk , Dan Eik Høfsten , Thomas Engstrøm
Eurointervention 13 ( 4) 381 -382
1
2017
Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy.
Lars Nepper-Christensen , Jacob Lønborg , Dan Eik Høfsten , Kiril Aleksov Ahtarovski
Eurointervention 14 ( 6) 700 -707
6
2018